'Safety efficacy' diaporamas de présentation

Why NMEs and Therapeutic Biological Products Fail in the First FDA Review Cycle

Why NMEs and Therapeutic Biological Products Fail in the First FDA Review Cycle. Partha Roy, Ph.D. | April 24, 2013. Positive Impact of PDUFA (1). Positive Impact of PDUFA (2). NMEs 1st cycle approval rates in the past 3 years . . . by APPROVAL Cohorts.

523 views • 40 slides

Community Clinical Oncology Program (CCOP)

Community Clinical Oncology Program (CCOP). Role of Data Safety Monitoring Board (DSMB) Mira Shah, CIM, CCRP. March 2011. Updated: July 2006. Disclaimer.

487 views • 30 slides

Wound Healing Gel

Wound Healing Gel. A Silver nanoparticle based hydrogel prepared by green synthesis. Novelty/Inventive component The product uses nanoparticle of silver formed by green synthesis Social Relevance Its an OTC product with vast market potential

837 views • 21 slides

Interviewing for the Pharmaceutical Industry: what does it involve and how to succeed?

Interviewing for the Pharmaceutical Industry: what does it involve and how to succeed? David P Brooks Interviewing for Pharma The Drug Discovery & Development Process What is Pharma Looking for? Attributes Finding the open positions The Interview process Working in Industry

694 views • 20 slides

Survey of KAP of Pediatricians regarding Hib Disease & Vaccination in India during Pedicon

Survey of KAP of Pediatricians regarding Hib Disease & Vaccination in India during Pedicon. Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI 2011-13 vipinipsita@gmail.com. Proposal

285 views • 15 slides

predict

235 views • 9 slides